Navigation Links
Stem Cell Assurance Announces the Filing of Its Form 10 Registration Statement
Date:5/12/2011

JUPITER, Fla., May 12, 2011 /PRNewswire/ -- Stem Cell Assurance, Inc. (SCLZ.PK) announced today that it has filed a General Form for Registration of Securities on Form 10 pursuant to Section 12(g) of the Securities Exchange Act of 1934.  The Form 10 includes audited financial statements as of December 31, 2009 and 2010 and for the years then ended.  Based upon this filing, effective July 11, 2011, the Company will become an SEC reporting company and will be subject to the requirements of the Exchange Act which will require the Company, among other things, to file annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.  

The effectiveness of the Form 10 on July 11, 2011 will facilitate the listing of the Company's shares on stock markets other than the Pink Sheets.

Mark Weinreb, the Company's Chief Executive Officer, stated, "We are very pleased to have made this filing which is another step in the development of our Company as a provider of important stem cell-related services."  

About Stem Cell Assurance, Inc.

Stem Cell Assurance, Inc.'s goal is to become a medical center of excellence using cell and tissue regenerative therapy protocols, primarily involving a patient's own (autologous) adult stem cells (non-embryonic), allowing patients to undergo cellular-based treatments. As more and more cellular therapies become standard of care, the Company believes its strength will be its focus on the unity of medical and scientific explanations for its future clinical procedures and outcomes and its incorporation of adult stem cell collection and storage services for future personal medical applications.  The Company also operates a wholly owned subsidiary, Stem Cellutrition™, which plans to offers facial creams and other skin care products.

CONTACTS
Mark Weinreb
CEO
Tel: (561) 904-6070
Fax: (561) 429-5684


'/>"/>
SOURCE Stem Cell Assurance, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Cytochroma appoints Steven I. Engel as Vice President of Regulatory Affairs and Quality Assurance
2. Hector Garcia Joins Particle Sciences as Director of Quality Assurance
3. Blue Dye Test Alternative Installed at Bayer China for Packaging Quality Assurance Process
4. Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance
5. Stem Cell Assurance Unveils Physician Network Offering Regenerative Cell Cosmetic and Reconstructive Applications
6. Joseph J. Ross, M.D., F.A.C.S. Joins Stem Cell Assurance as Vice Chairman
7. Stem Cell Assurance Announces Appointment of Mark Weinreb, M.S. as Chief Executive Officer and Board Member
8. Stem Cell Assurance to Open New Laboratory Facility in Jupiter, Florida
9. Stem Cell Assurance Announces Engagement of Marcum LLP as its Independent Auditors
10. Stem Cell Assurance Announces Hiring of Vice President of Research and Development
11. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... N.C. , Feb. 5, 2016  In the ... role for a host of launch activities including the ... of this launch activity is especially high in the ... Best Practices and the Role of Medical ... help companies focused on oncology therapies find better ways ...
(Date:2/5/2016)... FRANCISCO , February 5, 2016 ... a biotechnology company focused on developing products for ... has requested Rare Pediatric Disease Designation (RPDD) from the ... pigmentosa (RP) with MANF. MANF was previously granted orphan ... 2014. --> Amarantus BioScience Holdings, Inc. ...
(Date:2/4/2016)... CA (PRWEB) , ... February 04, 2016 , ... ... enterprise talent development and compliance training, today announced an interactive FDA compliance ... Playbook™. The RAPS (Regulatory Affairs Professional Society) accredited interactive course on Morf ...
(Date:2/4/2016)... , Feb. 4, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... announced today that Edward Lanphier , Sangamo,s president ... the progress of Sangamo,s ZFP Therapeutic ® development ... at 2:40 pm ET on Thursday, February 11, 2016, ... Healthcare Conference. The conference is being held in ...
Breaking Biology Technology:
(Date:2/1/2016)... NEW YORK , Feb. 1, 2016  Today, ... Heart Association (AHA) announced plans to develop a first ... cognitive computing power of IBM Watson. In the first ... disease, AHA, IBM (NYSE: IBM ), and Welltok ... metrics and health assessments with cognitive analytics, delivered on ...
(Date:1/25/2016)... Jan. 25, 2016  Glencoe Software, the world-leading supplier ... publication industries, will provide the data management solution OMERO ... Photo ... Phenotypic analysis measures the characteristics ... allowing comparisons between states such as health and disease, ...
(Date:1/20/2016)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce the attainment of record-setting corporate ... of the company,s laser focus on (and growing international ... comprehensive, easy-to-use and highly affordable cloud-based technology platform. ... growth achievements in 2015 include: , Record ...
Breaking Biology News(10 mins):